Publications by authors named "Raymond A Farkouh"

Claim this Profile
T
The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US.
Aleksandar Ilic, Maria J Tort, Alejandro Cane, Raymond A Farkouh, Mark H Rozenbaum

Vaccines (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants.
Mark H Rozenbaum, Liping Huang, Johnna Perdrizet, Alejandro Cane, Adriano Arguedas, Raymond A Farkouh

Vaccine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Response to: Letter to the Editor Regarding 'Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age'.
Mark H Rozenbaum, Johnna Perdrizet, Xiuyan Li, Matt D Wasserman, Lindsay R Grant, Raymond A Farkouh

Infect Dis Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines.
Johnna Perdrizet, Raymond A Farkouh, Emily K Horn, Kyla Hayford, Heather L Sings

Expert Rev Vaccines· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age.
Matt D Wasserman, Johnna Perdrizet, Lindsay Grant, Kyla Hayford, Shubhra Singh, Raymond A Farkouh

Infect Dis Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges.
Emily K Horn, Matt D Wasserman, Cassandra Hall-Murray, Heather L Sings, Ruth Chapman, Raymond A Farkouh

Expert Rev Vaccines· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium.
Michele R Wilson, Cheryl L McDade, Johnna E Perdrizet, Annick Mignon, Raymond A Farkouh

Infect Dis Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health and Economic Impact of Routine Pediatric Pneumococcal Immunization Programs in Canada: A Retrospective Analysis.
Michele R Wilson, Matthew D Wasserman, Marie-Claude Breton, Francois Peloquin, Stephanie R Earnshaw, Raymond A Farkouh

Infect Dis Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium.
Matt D Wasserman, Heather L Sings, Michele R Wilson, Maarten J Postma, Marie-Claude Breton, Raymond A Farkouh

Infect Dis Ther· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions.
Derek Weycker, Raymond A Farkouh, David R Strutton, John Edelsberg, Kimberly M Shea

BMC Health Serv Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of pneumonia among children and adults with chronic medical conditions in Germany.
Stephen I Pelton, Kimberly M Shea, Raymond A Farkouh, David R Strutton, Sebastian Braun

BMC Infect Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Despite High Cost, Improved Pneumococcal Vaccine Expected To Return 10-Year Net Savings Of $12 Billion.
Michele A Kohli, Raymond A Farkouh, Michael J Maschio, Lisa J McGarry, David R Strutton

Health Aff (Millwood)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".
Raymond A Farkouh, Cassandra Hall-Murray, Rogier M Klok, Betsy Hilton, Raul E Isturiz

Infect Dis Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking risk for pneumococcal disease in adults: the role of risk stacking.
Stephen I Pelton, Kimberly M Shea, Derek Weycker, Raymond A Farkouh, David R Strutton

Open Forum Infect Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine.
Stephen I Pelton, Derek Weycker, Raymond A Farkouh, David R Strutton, Kimberly M Shea

Clin Infect Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of pneumococcal disease in adults with chronic medical conditions.
Kimberly M Shea, John Edelsberg, Derek Weycker, Raymond A Farkouh, David R Strutton

Open Forum Infect Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor.
Rogier M Klok, Rose-Marie Lindkvist, Mats Ekelund, Raymond A Farkouh, David R Strutton

Clin Ther· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Rogier M Klok, Rose-Marie Lindkvist, Mats Ekelund, Raymond A Farkouh, David R Strutton

Clin Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions.
Raymond A Farkouh, Rogier M Klok, Maarten J Postma, Craig S Roberts, David R Strutton

Expert Rev Vaccines· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the impact of the 13-valent pneumococcal conjugate vaccine serotype catch-up program using United States claims data.
David R Strutton, Raymond A Farkouh, Jaime L Rubin, Lisa J McGarry, Paul M Loiacono

BMC Infect Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.
Stephanie R Earnshaw, Cheryl L McDade, Giovanni Zanotti, Raymond A Farkouh, David Strutton

BMC Infect Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.
David R Strutton, Raymond A Farkouh, Stephanie R Earnshaw, Sharon Hwang, Ulrike Theidel

J Infect· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United States.
Thomas N Taylor, Raymond A Farkouh, Jonathan B Graham, Antje Colligs, Marion Lindemann

Am J Obstet Gynecol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV.
Teresa L Kauf, Raymond A Farkouh, Stephanie R Earnshaw, Maria E Watson, Penny Maroudas

Pharmacoeconomics· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis